Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina

Circulation

Volumn 102, Issue 9, 2000, Pages 1007-1013

  Cipollone, Francesco ^a   Ciabattoni, Giovanni ^b   Patrignani, Paola ^a   Pasquale, Massimo ^a   Di Gregorio, Domenico ^c   Bucciarelli, Tonino ^a   Dav', Giovanni ^a   Cuccurullo, Franco ^a   Patrono, Carlo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c F Renzetti Hospital   (Italy)

Author keywords

Angina; Aspirin; Isoprostanes; Oxidant stress; Thromboxane

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID; CYCLOOXYGENASE 1; ICOSANOID; THROMBOXANE A2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL; UNSTABLE ANGINA PECTORIS;

EID: 0034730075     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.9.1007     Document Type: Article

References (35)

1. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls
2. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
3. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome
4. The antioxidant vitamins and cardiovascular disease
5. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
6. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase free radical-catalyzed mechanism
7. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease
8. 2-isoprostane) metabolites in human urine and plasma
9. 2(α) excretion in man
10. 2-isoprostanes) in smokers: Smoking as a cause of oxidative damage
11. Modulation of oxidant stress in vivo in chronic cigarette smokers
12. 2(α) and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation
13. 2(α) is increased in hypercholesterolemia
14. 2 isoprostanes in hypercholesterolemia
15. Platelet activation in unstable coronary disease
16. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina
17. Unstable angina
18. High-performance liquid chromatographic method for routine determination of vitamins A and E and β carotene in plasma
19. 2 in human plasma and urine
20. The mechanism of the effect of aspirin on human platelets: Acetylation of a particular protein fraction
21. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
22. 2-isoprostanes formation
23. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
24. 2(α) generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo
25. 2(α), in acute coronary angioplasty: Evidence for oxidant stress during coronary reperfusion in humans
26. 2(α)
27. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
28. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
29. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases
30. 2-isoprostanes in human atherosclerotic lesions
31. 2-isoprostanes to plaque instability in human carotid atherosclerosis
32. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
33. 2α) increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of nitric oxide
34. 2(α) is not mediated by thromboxane receptor isoforms
35. Eicosanoids and iso-eicosanoids: Constitutive, inducible and transcellular biosynthesis in vascular disease